摘要
青光眼是继白内障之后世界范围内第二位的致盲眼病,同时也是最常见的不可逆性致盲眼病,青光眼肓的严峻形势正逐步凸现。我国是世界上最大的发展中国家,原发性闭角型青光眼(primary angle closure glaucoma,PACG)患病率较高,随着人口老龄化进程,PACG和"可关闭房角"的患者数量还将进一步增大。我国当前PACG防治模式面临着诸多问题,卫生资源匮乏且分布不均衡,缺乏符合我国国情的诊治规范,存在着过度治疗现象。本文针对当前PACG防治模式的特点和问题,从循证医学和卫生经济学双重角度作一阐述,并进一步对今后的临床与科研工作提出改进意见。
Glaucoma is the first leading cause of irreversible blindness globally. China is one of the major developing countries and has the biggest burden of primary angle closure glaucoma （PACG） in the world. As the aged population grows in China, the amount of patients of PACG and ＂occludable angle＂ will be increased consequently. China is facing a number of barriers in the prevention of glaucomatous blindness such as unbalanced allocation of heahhcare resources, lack of evidence-based guidelines of glaucoma in accordance with Chinese situation, and sequential severe over-treatment. In this article, we reviewed the current mode of the prevention of glaucomatous blindness in China from the point of view of evidence-based medicine and health economics, and provided several suggestions in further researches and clinical works.
出处
《眼科》
CAS
2008年第6期424-429,共6页
Ophthalmology in China
基金
国家十一五科技支撑项目(2007BAI18B08)
关键词
循证医学
卫生经济学
原发性闭角型青光眼/治疗
evidence-based medicine
health economics
primary angle closure glaucoma/treatment
